Slope | Jotup

OneRail Recognized in 2023 Gartner® Hype Cycle™ for Smart City Technologies and Solutions

Retrieved on:

Tuesday, November 14, 2023

Software, Data Management, Trucking, Technology, Supply Chain Management, Logistics, Transport, Retail, Research, Slope, Gartner hype cycle, City, VRS, LMD, Publication, Risk management, Online shopping, Gartner

OneRail , a leading provider of solutions in last mile omnichannel fulfillment, recently announced that it had been positioned by Gartner as a Sample Vendor for Last Mile Delivery Solutions in the 2023 Gartner Hype Cycle for Smart City Technologies and Solutions.

Key Points:

OneRail , a leading provider of solutions in last mile omnichannel fulfillment, recently announced that it had been positioned by Gartner as a Sample Vendor for Last Mile Delivery Solutions in the 2023 Gartner Hype Cycle for Smart City Technologies and Solutions.
A smart city is designed to achieve a sustainable and people-centric quality of life by creating an intelligent urban ecosystem.
Most recently, OneRail was recognized in Hype Cycle for Supply Chain Technologies (2023) for the second time in a row.
Gartner Research Methodology, “Hype Cycle,” 9 November 2023. https://www.gartner.com/en/research/methodologies/gartner-hype-cycle
Gartner, Hype Cycle for Smart City Technologies and Solutions, 2023, Bettina Tratz-Ryan, 31 July 2023
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission.

Slope Appoints Terry Edwards as Chief Operating Officer

Retrieved on:

Wednesday, December 13, 2023

Clinical trial, ChromeOS, Organizational culture, Management, Slope

RICHMOND, Va., Dec. 13, 2023 /PRNewswire/ -- Slope, a global clinical trial technology company that specializes in complex, sample-intensive clinical trials, today announced that it has appointed Terry Edwards to the role of Chief Operating Officer. As COO, Edwards will oversee operations and strategic vision to deliver a single complete solution for clinical trial execution throughout the biospecimen lifecycle.

Key Points:

RICHMOND, Va., Dec. 13, 2023 /PRNewswire/ -- Slope , a global clinical trial technology company that specializes in complex, sample-intensive clinical trials, today announced that it has appointed Terry Edwards to the role of Chief Operating Officer.
Edwards to oversee operations and strategic vision to deliver single complete solution for clinical trial execution.
"I am delighted to welcome Terry to the Slope executive leadership team," says Rust Felix, CEO at Slope.
For more about Edwards and his new role at Slope, click here .

Slope Appoints Mark Melton as VP of Scientific Operations and Development

Retrieved on:

Thursday, September 28, 2023

Data management, Software, Clinical trial, Data collection, Running, Patient, Medicine, Pharmaceutical industry, Management, Slope

RICHMOND, Va., Sept. 28, 2023 /PRNewswire/ -- Slope, a global clinical trial technology company that specializes in complex, sample-intensive clinical trials, announced today that Mark Melton has joined the team as VP of Scientific Operations and Development. This leadership team expansion expedites Slope's delivery of a single complete solution for clinical trial execution from study start-up to study close, combining software with consultative services and support.

Key Points:

RICHMOND, Va., Sept. 28, 2023 /PRNewswire/ -- Slope, a global clinical trial technology company that specializes in complex, sample-intensive clinical trials, announced today that Mark Melton has joined the team as VP of Scientific Operations and Development.
Melton to build out Slope's services around study startup, biospecimen operations, data management, and study closeout.
"I am excited to join Slope, and what this combined offering will mean for the industry," says Mark Melton, VP of Scientific Operations and Development at Slope.
"Mark is passionate about helping Slope streamline clinical research to help patients," says Hope Meely, Chief Clinical Officer at Slope.

OneRail Recognized in 2023 Gartner® Hype Cycle™ for Supply Chain Execution Technologies

Retrieved on:

Tuesday, August 1, 2023

OneRail , a leading provider of solutions in last mile omnichannel fulfillment, recently announced that it had been positioned by Gartner as a Sample Vendor for Last-Mile Delivery Solutions in Gartner Hype Cycle Supply Chain Execution Technologies, 2023.

Key Points:

OneRail , a leading provider of solutions in last mile omnichannel fulfillment, recently announced that it had been positioned by Gartner as a Sample Vendor for Last-Mile Delivery Solutions in Gartner Hype Cycle Supply Chain Execution Technologies, 2023.
As organizations continue to seek ways to optimize fleet operations, supply chain technology leaders can use the research in the Gartner Hype Cycle to develop adoption strategies that reflect their organization’s risk and opportunity profile priorities.
OneRail was also previously recognized as a Representative Vendor in the December 2022 Gartner Market Guide for Last-Mile Delivery Technology Solutions, a Sample Vendor in the June 2022 Gartner Hype Cycle for Supply Chain Execution Technologies, and a Representative Vendor in the December 2021 Gartner Market Guide for Vehicle Routing and Scheduling (VRS) and Last-Mile Technologies.
Gartner Research Methodology, “Hype Cycle,” 31 July 2023. https://www.gartner.com/en/research/methodologies/gartner-hype-cycle
Gartner, Hype Cycle for Supply Chain Execution Technologies, 2023, Dwight Klappich, 13 July 2023.

Slope, Leader in Modernizing Clinical Trial Execution, Joins CancerX as Founding Member

Retrieved on:

Friday, June 2, 2023

RICHMOND, Va., June 2, 2023 /PRNewswire/ -- Slope, the industry-leading provider of a clinical trial execution platform focusing on clinical inventory and sample management, announced today its role as a founding member of CancerX. This public-private partnership, which is a part of The White House's reignited national Cancer Moonshot, aims to revolutionize cancer research and treatment through the power of digital innovation. CancerX is co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), in collaboration with the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).

Key Points:

RICHMOND, Va., June 2, 2023 /PRNewswire/ -- Slope , the industry-leading provider of a clinical trial execution platform focusing on clinical inventory and sample management, announced today its role as a founding member of CancerX .
Slope will leverage its expertise in complex oncology clinical trials and tech innovation to accelerate treatments.
As a founding member of CancerX, Slope will leverage its expertise in complex oncology clinical trials and technological innovation to accelerate treatments and contribute to the ambitious goal of reducing cancer deaths by 50% over the next 25 years.
"We are honored to support CancerX's mission to bring innovation to the fight against cancer," said Hope Meely, Chief Clinical Officer at Slope.

Steeper Energy enters agreement with Topsoe to introduce complete waste-to-biofuel solution

Retrieved on:

Thursday, January 26, 2023

Engineering, Biomass, Aviation, Energy, Aviation biofuel, Hydrogen, HTL, SAF, Agriculture, Slope, Carbon, Forestry, Senior, Renewable energy, Topsoe

Steeper Energy (Steeper) and Topsoe sign a global licensing agreement for Steeper's Hydrofaction® technology, enabling Topsoe to offer a complete waste-to-fuel solution.

Key Points:

Steeper Energy (Steeper) and Topsoe sign a global licensing agreement for Steeper's Hydrofaction® technology, enabling Topsoe to offer a complete waste-to-fuel solution.
The agreement grants Topsoe the right to sublicense Steeper's Hydrofaction® technology, used for converting biomass to renewable biocrude oil.
COPENHAGEN, Denmark, Jan. 26, 2023 /PRNewswire/ - Topsoe, a global leader in carbon emission reduction technologies, and Steeper, a pioneer within biomass conversion technologies, have today signed a global licensing agreement for a complete waste-to-fuel solution.
With the agreement, Topsoe will be able to provide a complete waste-to-fuel technology solution and at the same time a one-stop solution for refineries, project developers, and industries having access to excess waste biomass.

VIZIO Unveils ‘Winter Watchland’

Retrieved on:

Tuesday, December 6, 2022

VIZIO (NYSE: VZIO) brings seasons greetings to SmartCast audiences with its annual rendition of Winter Watchland a collection of movies and shows, On Demand exclusives, holiday music and binge-worthy winter break escapes.

Key Points:

VIZIO (NYSE: VZIO) brings seasons greetings to SmartCast audiences with its annual rendition of Winter Watchland a collection of movies and shows, On Demand exclusives, holiday music and binge-worthy winter break escapes.
View the full release here: https://www.businesswire.com/news/home/20221206005482/en/
VIZIO Unveils Winter Watchland (Photo: Business Wire)
Winter Watchland is an all-in-one holiday destination on the VIZIO home screen.
Winter Watchland can be found on the VIZIO home screen with clickable banners that invite users to check out a dedicated collection of holiday programming.
Check out the Watchland collection and more on WatchFree+, available on all VIZIO SmartCast TVs.

Experience Winter's Warm Embrace with Legendary Events and Activities in North Dakota

Retrieved on:

Tuesday, December 6, 2022

BISMARCK, N.D., Dec. 6, 2022 /PRNewswire/ -- The snow has fallen, and cooler temperatures have returned to herald the start of Legendary winter experiences in North Dakota .

Key Points:

BISMARCK, N.D., Dec. 6, 2022 /PRNewswire/ -- The snow has fallen, and cooler temperatures have returned to herald the start of Legendary winter experiences in North Dakota .
The frosty air, landscapes kissed with snow crystals and wealth of snow-filled activities beckon North Dakotans and visitors outdoors to make the most of the season.
Throughout North Dakota, there are plenty of winter wonderlands to discover, and the warm welcome of the state's residents will make you feel right at home.
Additional activities include a youth ice fishing tournament, sledding, cross country skiing, ice hockey, fireworks, food and much more!

Slope Delivers Real-Time Clinical Supply Chain Insights with Launch of Study Dashboard for Sponsors

Retrieved on:

Tuesday, November 29, 2022

IP, SAN, Slope, Clinical data management, Clinical trial, Sponsor, Supply chain management, Collection, Pharmaceutical industry, Fine chemical

SAN FRANCISCO, Nov. 29, 2022 /PRNewswire/ -- Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced general availability of its interactive Study Dashboard for Sponsors to address challenges coordinating and overseeing clinical supply chain management for one or more clinical trials across multiple research sites. The new interactive interface delivers clinical trial sponsors with accurate, real-time insights into their clinical trial supply chains including lab kit, investigational product (IP), device, and ancillary clinical supply inventories at research sites, and the state of biological samples from collection through lab receipt. With the Study Dashboard for Sponsors, clinical trial sponsors can proactively identify and address inventory and biological sample issues to reduce clinical trial risk, control costs, improve the productivity of clinical trial stakeholders, and increase subject enrollment and retention.

Key Points:

Provides Biological Sample Journey and Clinical Supply Inventory Status Throughout Complex, Sample-Intensive Clinical Trials
SAN FRANCISCO, Nov. 29, 2022 /PRNewswire/ -- Slope , provider of the first eClinical Supply Chain Management (eCSCM) platform, announced general availability of its interactive Study Dashboard for Sponsors to address challenges coordinating and overseeing clinical supply chain management for one or more clinical trials across multiple research sites.
The new interactive interface delivers clinical trial sponsors with accurate, real-time insights into their clinical trial supply chains including lab kit, investigational product (IP), device, and ancillary clinical supply inventories at research sites, and the state of biological samples from collection through lab receipt.
With the Study Dashboard for Sponsors, clinical trial sponsors can proactively identify and address inventory and biological sample issues to reduce clinical trial risk, control costs, improve the productivity of clinical trial stakeholders, and increase subject enrollment and retention.
The interactive Study Dashboard for Sponsors supports drill-down from a list of a sponsor's research study protocols into detailed clinical supply inventory and biological sample data for each research site supporting the study.

Slope Expands Go-To-Market Team for its eClinical Supply Chain Management Platform with Two Industry Veterans

Retrieved on:

Wednesday, October 19, 2022

SAN FRANCISCO, Oct. 19, 2022 /PRNewswire/ -- Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced hiring two leaders with deep clinical trial expertise: Ben Carmel as Chief Revenue Officer and Matt Smith as Research Site Development Vice President. In his new role, Ben will engage with clinical trial sponsors and contract research organizations (CROs) to reduce clinical trial risks, rein in costs, improve the productivity of clinical trial collaborators, and increase subject enrollment and retention by moving the manual and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform. Matt will engage with top academic research centers (AMCs) and clinical research sites to raise awareness and adoption of the Slope eCSCM platform. AMCs and clinical research sites use a free version of Slope to manage their clinical supply inventory—lab kits, investigational products (IP), devices, ancillary clinical supplies, and biological samples—so they are prepared for every subject procedure and never lose a sample.

Key Points:

Matt will engage with top academic research centers (AMCs) and clinical research sites to raise awareness and adoption of the Slope eCSCM platform.
"There is a disconnect in the industry between how clinical research sites are expected to manage their clinical supply inventory and the tools they're given to accomplish that," said Matt.
"The industry knows that supply chain delays can delay trials and strain budgets for sponsors.
Connect with Matt on LinkedIn: https://www.linkedin.com/in/mattsmith8/
Slope eClinical Supply Chain Management Platform: https://www.slope.io/eclinical-supply-chain-management-platform
Four Reasons to Optimize Your Clinical Supply Chain Management: https://www.slope.io/blog/four-reasons-optimize-clinical-supply-chain-ma...
Collaboration Requirements for an eClinical Supply Chain Management Platform: https://www.slope.io/blog/collaboration-requirements-eclinical-supply-ch...
Real-time Visibility Requirements for an eClinical Supply Chain Management Platform: https://www.slope.io/blog/real-time-visibility-requirements-eclinical-su...
Traceable Chain of Custody Requirements for an eClinical Supply Chain Management Platform: https://www.slope.io/blog/traceable-chain-custody-requirements-eclinical...
Compliance Requirements for an eClinical Supply Chain Management Platform: https://www.slope.io/blog/compliance-requirements-eclinical-supply-chain...
eClinical Supply Chain Management Platform Requirements: https://www.slope.io/blog/eclinical-supply-chain-management-platform-req...
Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, early-phase clinical trials.